text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 132539-06-1 | Product Number: O0393


Purity: >98.0%(GC)(T)
  • 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
Contact Us ≥40 
2   ≥40 

*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.

Product Number O0393
Purity / Analysis Method >98.0%(GC)(T)
Molecular Formula / Molecular Weight C__1__7H__2__0N__4S = 312.44 
Physical State (20 deg.C) Solid
Storage Temperature 0-10°C
Condition to Avoid Heat Sensitive
Packaging and Container 1G-Glass Bottle with Plastic Insert (View image)
CAS RN 132539-06-1
Reaxys Registry Number 7655141
PubChem Substance ID 160871343
Merck Index (14) 6822
MDL Number


Appearance Light yellow to Amber to Dark green powder to crystal
Purity(GC) min. 98.0 %
Purity(Nonaqueous Titration) min. 98.0 %
Properties (reference)
Melting Point 194 °C(dec.)
Solubility in water Insoluble
Pictogram Pictogram
Signal Word Danger
Hazard Statements H301 : Toxic if swallowed.
H315 : Causes skin irritation.
H319 : Causes serious eye irritation.
H413 : May cause long lasting harmful effects to aquatic life.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P273 : Avoid release to the environment.
P270 : Do not eat, drink or smoke when using this product.
P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ eye protection/ face protection.
P302 + P352 : IF ON SKIN: Wash with plenty of water.
P337 + P313 : If eye irritation persists: Get medical advice/ attention.
P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P362 + P364 : Take off contaminated clothing and wash it before reuse.
P332 + P313 : If skin irritation occurs: Get medical advice/ attention.
P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth.
P405 : Store locked up.
Related Laws:
RTECS# XJ9007750
Transport Information:
UN Number UN2811
Class 6.1
Packing Group III
多受容体作用抗精神病薬 (MARTA),オランザピン

Olanzapine is known as a multi-acting receptor targeted antipsychotic (MARTA), such as clozapine [C2547] and quetiapine [Q0092]. Olanzapine has greater affinity for serotonin 5-HT2A and dopamine D2 receptors. Furthermore, olanzapine has various affinities for multiple receptors, including serotonin 5-HT2C, 5-HT6 receptors, dopamine D1-4, histamine H1, and adrenergic α1 receptors. In addition, olanzapine has moderate affinity binding for serotonin 5HT3 and muscarinic M1-5. While, olanzapine binds weakly to GABAA, benzodiazepine (BZD), and β-adrenergic receptors. The precise mechanism of action is unknown, but olanzapine is used as a thienobenzodiazepine atypical antipsychotic.
Recently, it is reported that the use of olanzapine combined with a 5-HT3 receptor antagonist, a neurokinin1 (NK1) receptor antagonist and dexamethasone [D1961] has improved the control of acute chemotherapy-induced nausea and vomiting. (The product is for research purpose only.)


PubMed Literature

Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number Incorrect Lot Number is entered

The requested analytical chart is not available. Sorry for the inconvenience.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.